Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 25-33

  Kuniyasu, Hiroki ^a   Ellis, Lee M ^a   Evans, Douglas B ^a   Abbruzzese, James L ^a   Fenoglio, Claudia J ^a   Bucana, Corazon D ^a   Cleary, Karen R ^a   Tahara, Eiichi ^b   Fidler, Isaiah J ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 8; UVOMORULIN; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; COLORIMETRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MORTALITY; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; CADHERINS; COLLAGENASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 9; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0032900985     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer Statistics. CA Cancer J. Clin., 44: 7-26, 1994.
2. Wingo, A. P., Tong, T., Bolden, S., Squire, T. S., and Taong, T. Cancer statistics, 1995. CA Cancer J. Clin., 5: 3-30, 1995.
3. Allen-Mersh, T. G. Significance of the site of origin of pancreatic exocrine adenocarcinoma. J. Clin. Pathol., 35: 544-546, 1982.
4. Nitecki, S. S., Sarr, M. G., Colby, T. V., and van Heerden J. A. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann. Surg., 221: 59-66, 1995.
5. Evans, D. B., Abbruzzese, J. L., and Rich, T. A. Cancer of the pancreas. In: V. T. deVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, 5th ed., pp. 1054-1087. Philadelphia: Lippincott-Raven Press, 1997.
6. Cameron, J. L., Crist, D. W., Sitzmann, J. V., Hruban, R. H., Boinott, J. K., Seider, A. J., and Coleman, J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg., 767: 120-125, 1991.
7. Connolly, M. M., Dawson, P. J., Michelassi, F., Moosa, A. R., and Lowenstein, F. Survival in 1001 patients with carcinoma of the pancreas. Ann. Surg., 206: 366-373, 1987.
8. Kayahara, M., Nagakawa, T., Ueno, K., Ohta, T., Takeda, T., and Miyazaki, I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer (Phila.), 72: 2118-2123, 1993.
9. Solcia, E., Capella, C., and Klöppel, G. Tumors of the pancreas. In: J. Rosai and L. H. Sobin (eds.), Atlas of Tumor Pathology, 3rd ed., pp. 31-144. Washington, DC: Armed Forces Institute of Pathology, 1997.
10. Miller, A. R., Robinson, E. K., Lee, J. E., Pisters, P. W. T., Chiao, P. J., Lenzi, R. L., Abbruzzese, J. L., and Evans, D. B. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg. Oncol. Clin. N. Am., 7: 183-197, 1998.
11. Spitz, F. R., Abbruzzese, J. L., Lee, J. E., Pisters, P. W., Lowy, A. M., Fenoglio, C. J., Cleary, K. R., Janjan, N. A., Goswitz, M. S., Rich, T. A., and Evans, D. B. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J. Clin. Oncol., 15: 928-937, 1997.
12. Staley, C. A., Lee, J. E., Cleary, K. R., Abbruzzese, J. L., Fenoglio, C. J., Rich, T. A., and Evans, D. B. Preoperative chemoprevention, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am. J. Surg., 171: 118-124, 1996.
13. Yasui, W., Yokozaki, H., and Tahara, E. Molecular diagnosis of gastrointestinal cancer. In: E. Tahara (ed.), Molecular Pathology of Gastroenterological Cancer, pp. 187-207. Tokyo: Springer-Verlag, 1997.
14. Almoguerra, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
15. Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K. K., Cameron, J. L., and Bos, J. L. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol., 143: 545-554, 1993.
16. Pellegata, N. S., Sessa, F., Renault, B., Bonato, M., Leone, B. E., Solcia, E., and Ranzani, G. N. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54: 1556-1560, 1994.
17. Hahn, S. A., and Kern, S. E. Molecular genetics of exocrine pancreatic neoplasms. Surg. Clin. N. Am., 75: 875-879, 1995.
18. Lee, E. Y., Cibull, M. L., O'Daniel-Pierce, E., Strodel, W. E., and Jennings, C. D. Expression of p53 protein in pancreatic adenocarcinoma. Int. J. Pancreatol., 17: 237-242, 1995.
19. Sinicrope, F. A., Evans, D. B., Leach, S. D., Cleary, K. R., Fenoglio, C. J., Lee, J. J., and Abbruzzese, J. L. Bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. Clin. Cancer Res., 2: 2015-2022, 1996.
20. Cadas, C., Hanh, S. A., da Costa, L. T., Redson, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MST1) gene in pancreatic adenocarcinomas. Nat. Genet., 8: 27-32, 1994.
21. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
22. Kitadai, Y., Ellis, L. M., Tucker, S. L., Greene, G. F., Bucana, C. D., Cleary, K. R., Takahashi, Y., Tahara, E., and Fidler, I. J. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am. J. Pathol., 149: 1541-1551, 1996.
23. Fidler, I. J., and Radinsky, R. Genetic control of cancer metastasis. J. Natl. Cancer Inst., 82: 166-168, 1990.
24. Kitadai, Y., Bucana, C. D., Ellis, L. M., Anzai, H., Tahara, E., and Fidler, I. J. In situ hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol., 147: 1238-1247, 1995.
25. Kitadai, Y., Ellis, L. M., Takahashi, Y., Bucana, C. D., Anzai, H., Tahara, E., and Fidler, I. J. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin. Cancer Res., 1: 1095-1102, 1995.
26. Anzai, H., Kitadai, Y., Bucana, C. D., Sanchez, R., Omoto, R., and Fidler, I. J. Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. Differentiation, 60: 119-127, 1996.
27. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., and Fidler, I. J. In situ mRNA hybridization technique for analysis of metastasis-related genes in human prostate carcinoma cells. Am. J. Pathol., 750: 1571-1582, 1996.
28. Takeichi, M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development (Camb.), 702: 639-655, 1988.
29. Takeichi, M. Cadherin cell adhesion receptor as a morphogenic regulator. Science (Washington DC), 251: 1451-1455, 1991.
30. Kadowaki, T., Shiozaki, H., Inoue, M., Tamura, S., Oka, H., Doki, Y., lihara, K., Matsui, S., Iwazawa, T., Nagafuchi, A., Tsukita, S., and Mori, T. E-Cadherin and α-catenin expression in human esophageal cancer. Cancer Res., 54: 291-296, 1994.
31. Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., and Funke, I. E-Cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 53: 1690-1695, 1993.
32. Yasui, W., Kuniyasu, H., Akama, Y., Kitahara, K., Nagafuchi, A., Ishihara, S., Tsukita, S., and Tahara, E. Expression of E-cadherin, α- and β-catenins in human gastric carcinomas: correlation with histology and tumor progression. Oncol. Rep., 2: 111-117, 1995.
33. Dorudi, S., Sheffield, J. P., Poulsom, R., Northover, J. M., and Hart, I. R. E-Cadherin expression in colorectal cancer: an immunocytochemical and in situ hybridization study. Am. J. Pathol., 142: 981-986, 1993.
34. Brabant, G., Hoang-Yu, C., Cetin, Y., Dralle, H., Scheumann, G., Moelne, J., Hansson, G., Jansson, S., Ericson, L. E., and Nisson, M. E-Cadherin: a differentiation marker in thyroid malignancies. Cancer Res., 53: 4987-4993, 1993.
35. Mattijssen, V., Peters, H. M., Schalkwijk, L., Manni, J. J., Van't Hof Grootenboer, B., de Mulder, P. H., and Ruiter, D. J. E-Cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer, 55; 580-585, 1993.
36. Gamallo, C., Palacios, J., Suarez, A., Pizamo, A., Navarro, P., Quintanilla, M., and Cana, A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol., 142: 987-993, 1993.
37. Umbas, R., Schalken, J. A., Alders, T. W., Carter, B. S., Karthas, H. F. M., Schaafsma, H. E., Debruyne, F. M. J., and Issacs, W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104-5109, 1992.
38. Vleminckx, K., Vakaet, Jr., L., Mareel, M., Fiers, W., and Van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
39. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Loechner, D., and Birchmeier, W. E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
40. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Selzter, J. L., Kronberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6579-6587, 1988.
41. Welgus, H. G., Campbell, E. J., Cury, J. D., Eisen, A. Z., Senior, R. M., Wilhelm, S. M., and Goldberg, G. I. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J. Clin. Investig., 86: 1496-1502, 1990.
42. Campbell, E. J., Cury, J. D., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol., 146: 1286-1293, 1991.
43. D'Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler-Stevenson, W. G., and Grigioni, W. F. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod. Pathol., 4: 239-246, 1991.
44. Liotta, L. A. Tumor invasion and metastasis-role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res., 46: 1-7, 1986.
45. Bucana, C. D., Radinsky, R., Dong, Z., Sanchez, R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr-1 in mouse colon carcinoma cells. J. Histochem. Cytochem., 41: 499-506, 1993.
46. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943, 1993.
47. th ed., pp. 121-126. Philadelphia: Lippincott-Raven, 1997.
48. Ullich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V., Whittle, N., Waterfield, M. D., and Seeburg, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-428, 1984.
49. Singh, R. K., Bucana, C. D., Gutman, M., Fan, D., Wilson, M. R., and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol., 145: 365-374, 1994.
50. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagusbrun, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1998.
51. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
52. Tischer, E., Mitchell, R., Hartman, T., Suva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
53. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appela, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J. Exp. Med., 767: 1883-1893, 1988.
54. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
55. Bussenmakers, M. J. G., van Bokhoven, A., Mees, S. G. M., Kemler, R., and Schalken, J. A. Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol. Rep., 7: 123-128, 1993.
56. Pearson, W. R., and Lipman, D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA, 85: 2444-2448, 1988.
57. Park, C-S., Manahan, L. J., and Brigati, D. J. Automated molecular pathology: one hour in situ DNA hybridization. J. Histotechnol., 14: 219-229, 1991.
58. Caruthers, M. H., Beaucage, S. L., Efcavitch, J. W., Fisher, E. F., Goldman, R. A., DeHaseth, P. L., Mandecki, W., Matteucci, M. D., Rosendahl, M. S., and Stabinsky, Y. Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harbor Symp. Quant. Biol., 47: 411-418, 1982.
59. Reed, J. A., Manahan, L. J., Park, C. S., and Brigati, D. J. Complete one-hour immunocytochemistry based on capillary action. Biotechniques, 13: 434-443, 1992.
60. Fisher, L. D., and van Belle, G. Biostatistics, pp. 786-843. New York: Wiley, 1993.
61. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-481, 1958.
62. 2/E in survival data. Biometrics, 31: 957-961, 1975.
63. Cox, D. R. Regression models and life tables. J. Royal Stat. Soc. (B), 34: 187-220, 1972.
64. Nagakawa, T., Mori, K., Nakano, T., Kadoya, M., Kobayashi, H., Akiyama, T., Kayahara, M., Ohta, T., Ueno, K., Higashino, Y., Konishi, I., and Miyazaki, I. Perineural invasion of carcinoma of the pancreas and biliary tract. Br. J. Surg., 80: 619-621, 1993.
65. Nagakawa, T., Nagamori, M., Futakami, F., Tsukioka, Y., Kayahara, Y., Ohta, T., Ueno, K., and Miyazaki, I. Results of extensive surgery for pancreatic carcinoma. Cancer (Phila.), 77: 640-645, 1996.
66. Kobari, M., Sunamura, M., Ohashi, O., Saitoh, Y., Yasa, T., and Matsuno, S. Usefulness of Japanese staging in the prognosis of patients treated operatively for adenocarcinoma of the head of the pancreas. J. Am. Coll. Surg., 182: 24-32, 1996.
67. Sperti, C., Pasquarli, C., Piccoli, A., and Pedrazzoli, S. Survival after resection for ductal adenocarcinoma of the pancreas. Br. J. Surg., 83: 625-631, 1996.
68. Fidler, I. J. Critical factors in the biology of human cancer metastasis: Twenty-eighth GHA Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
69. 125I-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst., 45: 773-782, 1970.
70. Fidler, I. J., and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science (Washington DC), 797: 893-895, 1977.
71. Takeichi, M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem., 59: 237-252, 1990.
72. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimasato, Y., Takeichi, M., and Abe, O. Cadherin cell adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49: 2128-2133, 1989.
73. Oka, H., Shiozaki, H., Kobayashi, H., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M., and Mori, T. Expression of E-cadherin cell adhesion molecule in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53: 1696-1701, 1993.
74. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W. E-Cadherin expression in squamous carcinomas of the head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 57: 6328-6337, 1991.
75. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51: 2185-2192, 1991.
76. Liotta, L. A., and Stetler-Stevenson, W. G. Metalloproteinases and cancer invasion. Semin. Cancer Biol., 7: 99-106, 1990.
77. Matrisian, L. M., and Bowden, G. T. Stromelysin/transin and tumor progression. Semin. Cancer Biol., 1: 107-115, 1990.
78. Murphy, G., and Docherty, A. J. P. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol., 7: 120-125, 1992.
79. Stetler-Stevenson, W. G. Type IV collagenase in tumor invasion and metastases. Cancer Metastasis Rev., 9: 289-303, 1990. 7
80. Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D., and Stetler-Stevenson, W. G. Tumor cell invasion by TIMP-2. J. Natl. Cancer Inst., 83: 775-779, 1991.
81. DeClerck, Y. A., Yean, T-D., Chan, D., Shimada, H., and Landley, K. E. Inhibition of tumor invasion of smooth muscle cell layer by recombinant human metalloproteinase inhibitor. Cancer Res., 57: 2151-2157, 1991.
82. Conlon, K. C., Klimstra, D. S., and Brennan, M. F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann. Surg., 223: 273-279, 1996.
83. Seki, H., Tanaka, J., Sato, Y., Kalo, Y., Umezawa, A., and Koyama, K. Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer. J. Surg. Oncol., 53: 78-83, 1993.